231 related articles for article (PubMed ID: 34417291)
21. CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.
Nishioka Y; Masuda S; Tomaru U; Ishizu A
Front Immunol; 2018; 9():548. PubMed ID: 29599785
[TBL] [Abstract][Full Text] [Related]
22. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
23. Unappreciated diversity within the pool of CD1d-restricted T cells.
Pellicci DG; Uldrich AP
Semin Cell Dev Biol; 2018 Dec; 84():42-47. PubMed ID: 29183709
[TBL] [Abstract][Full Text] [Related]
24. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
Pellicci DG; Patel O; Kjer-Nielsen L; Pang SS; Sullivan LC; Kyparissoudis K; Brooks AG; Reid HH; Gras S; Lucet IS; Koh R; Smyth MJ; Mallevaey T; Matsuda JL; Gapin L; McCluskey J; Godfrey DI; Rossjohn J
Immunity; 2009 Jul; 31(1):47-59. PubMed ID: 19592275
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
26. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.
Arrenberg P; Halder R; Dai Y; Maricic I; Kumar V
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10984-9. PubMed ID: 20534460
[TBL] [Abstract][Full Text] [Related]
27. Antigen recognition by CD1d-restricted NKT T cell receptors.
Godfrey DI; Pellicci DG; Patel O; Kjer-Nielsen L; McCluskey J; Rossjohn J
Semin Immunol; 2010 Apr; 22(2):61-7. PubMed ID: 19945889
[TBL] [Abstract][Full Text] [Related]
28. Recognition of CD1d-restricted antigens by natural killer T cells.
Rossjohn J; Pellicci DG; Patel O; Gapin L; Godfrey DI
Nat Rev Immunol; 2012 Dec; 12(12):845-57. PubMed ID: 23154222
[TBL] [Abstract][Full Text] [Related]
29. The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions.
Macho-Fernandez E; Brigl M
Front Immunol; 2015; 6():362. PubMed ID: 26284062
[TBL] [Abstract][Full Text] [Related]
30. Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor.
Patel O; Pellicci DG; Gras S; Sandoval-Romero ML; Uldrich AP; Mallevaey T; Clarke AJ; Le Nours J; Theodossis A; Cardell SL; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2012 Sep; 13(9):857-63. PubMed ID: 22820603
[TBL] [Abstract][Full Text] [Related]
31. Ascites specific inhibition of CD1d-mediated activation of natural killer T cells.
Webb TJ; Giuntoli RL; Rogers O; Schneck J; Oelke M
Clin Cancer Res; 2008 Dec; 14(23):7652-8. PubMed ID: 19047090
[TBL] [Abstract][Full Text] [Related]
32. Complexity and function of natural killer T cells with potential application to hepatic transplant survival.
Ware R; Kumar V
Liver Transpl; 2017 Dec; 23(12):1589-1592. PubMed ID: 28945950
[TBL] [Abstract][Full Text] [Related]
33. Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.
López-Sagaseta J; Sibener LV; Kung JE; Gumperz J; Adams EJ
EMBO J; 2012 Apr; 31(8):2047-59. PubMed ID: 22395072
[TBL] [Abstract][Full Text] [Related]
34. The molecular bases of δ/αβ T cell-mediated antigen recognition.
Pellicci DG; Uldrich AP; Le Nours J; Ross F; Chabrol E; Eckle SB; de Boer R; Lim RT; McPherson K; Besra G; Howell AR; Moretta L; McCluskey J; Heemskerk MH; Gras S; Rossjohn J; Godfrey DI
J Exp Med; 2014 Dec; 211(13):2599-615. PubMed ID: 25452463
[TBL] [Abstract][Full Text] [Related]
35. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands.
Florence WC; Xia C; Gordy LE; Chen W; Zhang Y; Scott-Browne J; Kinjo Y; Yu KO; Keshipeddy S; Pellicci DG; Patel O; Kjer-Nielsen L; McCluskey J; Godfrey DI; Rossjohn J; Richardson SK; Porcelli SA; Howell AR; Hayakawa K; Gapin L; Zajonc DM; Wang PG; Joyce S
EMBO J; 2009 Nov; 28(22):3579-90. PubMed ID: 19816402
[TBL] [Abstract][Full Text] [Related]
36. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.
Girardi E; Zajonc DM
Immunol Rev; 2012 Nov; 250(1):167-79. PubMed ID: 23046129
[TBL] [Abstract][Full Text] [Related]
38. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors.
Brigl M; van den Elzen P; Chen X; Meyers JH; Wu D; Wong CH; Reddington F; Illarianov PA; Besra GS; Brenner MB; Gumperz JE
J Immunol; 2006 Mar; 176(6):3625-34. PubMed ID: 16517731
[TBL] [Abstract][Full Text] [Related]
39. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.
Venkataswamy MM; Porcelli SA
Semin Immunol; 2010 Apr; 22(2):68-78. PubMed ID: 19945296
[TBL] [Abstract][Full Text] [Related]
40. Discrete TCR Binding Kinetics Control Invariant NKT Cell Selection and Central Priming.
Cruz Tleugabulova M; Escalante NK; Deng S; Fieve S; Ereño-Orbea J; Savage PB; Julien JP; Mallevaey T
J Immunol; 2016 Nov; 197(10):3959-3969. PubMed ID: 27798168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
